Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro(3))GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice

Research output: Contribution to journalArticlepeer-review

84 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro(3))GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice'. Together they form a unique fingerprint.

Medicine & Life Sciences